Novel IASs bearing N-substituted piperidine at indole-2-carboxamide were designed. New IASs have EC50 values ranging from 0.62 μM to 0.006 μM against WT HIV-1. Compounds 8 (EC50 = 6 nM) and 18 (EC50 = 9 nM) were the most active derivatives. Compounds 8 and 18 also displayed outstanding potency against some HIV-1 mutants. SARs and molecular modeling studies were discussed in detail.